China says tests on plasma products negative for HIV | Inquirer ºÚÁÏÉç

ºÚÁÏÉç

China says tests on plasma products negative for HIV

/ 01:59 PM February 07, 2019

BEIJING — Chinese investigators said Thursday tests on a batch of a plasma product feared to have been contaminated with HIV have turned up negative for the virus that causes AIDS.

The result appears to have headed off the possibility of yet another scandal involving medical products in the country. Incidents include the falsifying of production records for rabies vaccines that prompted a nationwide crackdown on the industry and the injecting of other faulty vaccines.

Public outrage over such scandals has alarmed the leadership of the ruling Communist Party, moving it to respond more quickly and firmly than in the past, including bringing criminal charges and billion dollar fines.

Article continues after this advertisement

A statement from the National Medical Products Administration said tests for HIV, hepatitis B, and hepatitis C all turned out negative. The samples were from a batch of 12,000 plasma products manufactured by Shanghai-based China Meheco Xinxing Pharma Co., Ltd.

During the 1990s and earlier 2000s, thousands of Chinese were infected with HIV when they sold blood that was pooled and the plasma removed. In the past, deaths and injuries have also been blamed on shoddy medicines, baby formula, toys, and other products. /kga

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the and acknowledge that I have read the .

EDITORS' PICK
business
www
lifestyle
sports
cebudailynews
globalnation
TAGS: AIDS, China, ºÚÁÏÉç, plasma, rabies, Vaccines, Virus, world, world news

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the and acknowledge that I have read the .

© Copyright 1997-2025 ºÚÁÏÉç | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies.